about
The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusCan estrogens promote hypertension during systemic lupus erythematosus?Role of cardiovascular imaging in systemic autoimmune diseasesEstrogen in cardiovascular disease during systemic lupus erythematosusAdiponectin in cardiovascular inflammation and obesityStatins induce the accumulation of regulatory T cells in atherosclerotic plaqueImpaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune diseaseIncreased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis.Atherosclerosis: immune and inflammatory aspects.Perceptions regarding a range of work-related issues and corresponding support needs of individuals with an intractable disease.Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems.Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.Carotid-Femoral Pulse Wave Velocity in the Prediction of Cardiovascular Events and Mortality: An Updated Systematic Review and Meta-Analysis.Immune-Mediated Heart Disease.Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases.
P2860
Q28486062-445FC978-F260-4E26-BFC5-97B86B1AF98FQ33961468-9313DD9F-BAB5-4162-8EE4-B11895AB6D65Q34390705-CE27BEAF-212E-4C1C-BA35-89A22E61B3B1Q35162962-B9872453-2B10-4D6C-9D38-7721F24549C7Q35219362-1FCDDB76-3977-4EFF-A587-3A6A1A4E1008Q36071708-3633B9A4-1C09-48FA-8A81-8B65A78EE36CQ36399434-BD68AAFD-4636-4156-9E8B-F5A22B0228BEQ36411062-0B07305B-19AD-4333-AA1E-684137DB1D04Q36583651-2C3F7E3A-62E1-4921-9802-F9FF18271334Q37198705-E0FEADAD-FE36-4DA8-9DDB-945F76E8B02DQ37350506-3611CA37-334F-434C-98F7-5CAA7F877549Q37362915-477F7367-FDA4-4009-A62C-9FBB5E83654EQ38840236-45609A68-316D-4030-8260-AB8F9CF5F78CQ45129989-C01D9967-479B-4C3B-9325-0D16895B7304Q48238562-A23B415B-3304-49D8-A1C7-B92712AA90DDQ51835838-FE6693DE-AF20-4447-A038-B942A1B9512FQ55096371-354D3BD1-5570-4932-8ABA-F2351F069A2E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiac involvement in systemic autoimmune diseases.
@ast
Cardiac involvement in systemic autoimmune diseases.
@en
Cardiac involvement in systemic autoimmune diseases.
@nl
type
label
Cardiac involvement in systemic autoimmune diseases.
@ast
Cardiac involvement in systemic autoimmune diseases.
@en
Cardiac involvement in systemic autoimmune diseases.
@nl
prefLabel
Cardiac involvement in systemic autoimmune diseases.
@ast
Cardiac involvement in systemic autoimmune diseases.
@en
Cardiac involvement in systemic autoimmune diseases.
@nl
P2093
P356
P1476
Cardiac involvement in systemic autoimmune diseases.
@en
P2093
Cristina Luzzana
Luca Catelli
Maria Gerosa
Piersandro Riboldi
P2888
P304
P356
10.1385/CRIAI:23:3:247
P577
2002-12-01T00:00:00Z
P6179
1018083440